BioCanvas
표적 · AGPT2

AGPT2 항체

2최다 인용
25인용된 항체
12벤더
Antibody Registry데이터 출처 · RRID CC0

논문 인용순 항체

Antibody Registry 인용수 기준 · 25종
1
Abcam#ab56301 RRID:AB_2226229 monoclonal
2
cited by
2
Syd Labs#PA000156-PA1005-1 RRID:AB_2226215 polyclonal
1
cited by
3
Santa Cruz Biotechnology#sc-7017 RRID:AB_2226218 polyclonal
1
cited by
4
Cell Signaling Technology#2948 RRID:AB_2289507 polyclonal
1
cited by
5
GenWay Biotech Inc.#18-272-195156-0.025 mg RRID:AB_997475 polyclonal
0
cited by
6
Novus#NBP1-03019 RRID:AB_1520255 polyclonal
0
cited by
7
US Biological#A2293-19 RRID:AB_2226212 polyclonal
0
cited by
8
US Biological#A2293-11 RRID:AB_2226213 polyclonal
0
cited by
9
Biotrend#ANG21-A RRID:AB_2226221 polyclonal
0
cited by
10
Millipore#AB3121 RRID:AB_2226222 polyclonal
0
cited by
11
Santa Cruz Biotechnology#sc-20718 RRID:AB_2226224 polyclonal
0
cited by
12
Cell Sciences#CMA105 RRID:AB_2226231 monoclonal
0
cited by
13
Innovative Research#tmp_1048 RRID:AB_2226232 polyclonal
0
cited by
14
Millipore#176002 RRID:AB_2258210 polyclonal
0
cited by
15
Biotrend#ANG21-S RRID:AB_2258211 polyclonal
0
cited by
16
US Biological#A2293-10A RRID:AB_2289509 polyclonal
0
cited by
17
Biotrend#100-401-402 RRID:AB_2305443 polyclonal
0
cited by
18
Creative Diagnostics#CABT-26424MH RRID:AB_2347126 monoclonal
0
cited by
19
Creative Diagnostics#CPBT-27817RM RRID:AB_2361848 unknown
0
cited by
20
Creative Diagnostics#CPBT-27818GH RRID:AB_2361849 unknown
0
cited by
21
Creative Diagnostics#DCABH-4473 RRID:AB_2478243 monoclonal
0
cited by
22
Creative Diagnostics#DCABY-3932 RRID:AB_2496026 monoclonal
0
cited by
23
Creative Diagnostics#DCABY-4263 RRID:AB_2496321 monoclonal
0
cited by
24
Creative Diagnostics#DPABH-22367 RRID:AB_2505021 unknown
0
cited by
25
Creative Diagnostics#DPABH-03989 RRID:AB_2508780 unknown
0
cited by
이 표적 항체를 국내 공급가·납기로 확인하시겠어요? 국내 구매·견적 문의 →

AGPT2

이 표적에 논문에서 가장 많이 인용된 항체 순으로 정리했습니다. 각 행에서 국내 견적을 요청할 수 있습니다.

Data: Antibody Registry (SciCrunch) — RRID under CC-0; product metadata per respective source. Citation counts: Antibody Registry.